Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.815 USD | -2.43% | +1.13% | +25.43% |
May. 09 | Pluri Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
May. 02 | Pluri Inc. Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment | CI |
Financials (USD)
Sales 2022 | 234K | Sales 2023 | 287K | Capitalization | 32.98M |
---|---|---|---|---|---|
Net income 2022 | -41M | Net income 2023 | -28M | EV / Sales 2022 | 58 x |
Net cash position 2022 | 26.21M | Net cash position 2023 | 10.27M | EV / Sales 2023 | 79.1 x |
P/E ratio 2022 |
-0.96
x | P/E ratio 2023 |
-1.04
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 76.12% |
1 day | -2.43% | ||
1 week | +1.13% | ||
Current month | +3.84% | ||
1 month | +0.26% | ||
3 months | -6.54% | ||
6 months | +20.01% | ||
Current year | +25.43% |
Managers | Title | Age | Since |
---|---|---|---|
Yaky Yanay
CEO | Chief Executive Officer | 52 | 06-10-31 |
Director of Finance/CFO | 40 | 13-04-30 | |
Zami Aberman
CHM | Chairman | 70 | 05-09-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 21-07-14 | |
Lorne Abony
BRD | Director/Board Member | 55 | 23-07-10 |
Zami Aberman
CHM | Chairman | 70 | 05-09-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 5.815 | -2.43% | 3,501 |
24-05-09 | 5.96 | +1.53% | 6,263 |
24-05-08 | 5.87 | -0.34% | 4,652 |
24-05-07 | 5.89 | +5.18% | 5,623 |
24-05-06 | 5.6 | -2.61% | 21,746 |
Delayed Quote Nasdaq, May 10, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+25.43% | 31.34M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- PLUR Stock